Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             119 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A common pathway mediated through Toll-like receptors leads to T- and natural killer–cell immunosuppression Vaknin, Ilan

111 3 p. 1437-1447
artikel
2 Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells Secchiero, Paola

111 3 p. 1287-1294
artikel
3 Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin Rhodes, Melissa M.

111 3 p. 1700-1708
artikel
4 Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released Italiano Jr, Joseph E.

111 3 p. 1227-1233
artikel
5 An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression Marques, Celio A.

111 3 p. 1413-1419
artikel
6 Anorexia nervosa: marrow morphology
111 3 p. 987
artikel
7 Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia Yang, Jun

111 3 p. 1610-1616
artikel
8 Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3) You, Ren-In

111 3 p. 1480-1488
artikel
9 Application of high-throughput screening to identify a novel αIIb-specific small- molecule inhibitor of αIIbβ3-mediated platelet interaction with fibrinogen Blue, Robert

111 3 p. 1248-1256
artikel
10 4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cells Kim, Young-June

111 3 p. 1378-1386
artikel
11 BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma. Niesvizky, Ruben

111 3 p. 1101-1109
artikel
12 Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell–mediated lysis of myeloma Shi, Jumei

111 3 p. 1309-1317
artikel
13 Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report Doolittle, Nancy D.

111 3 p. 1085-1093
artikel
14 Cbfβ-SMMHC impairs differentiation of common lymphoid progenitors and reveals an essential role for RUNX in early B-cell development Kuo, Ya-Huei

111 3 p. 1543-1551
artikel
15 CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer Garçon, Fabien

111 3 p. 1464-1471
artikel
16 Characterization and localization of side population (SP) cells in zebrafish kidney hematopoietic tissue Kobayashi, Isao

111 3 p. 1131-1137
artikel
17 Characterization of in vitro antimurine thymocyte globulin–induced regulatory T cells that inhibit graft-versus-host disease in vivo Ruzek, Melanie C.

111 3 p. 1726-1734
artikel
18 Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML Gondek, Lukasz P.

111 3 p. 1534-1542
artikel
19 Clinical stem-cell sources contain CD8+CD3+ T-cell receptor–negative cells that facilitate bone marrow repopulation with hematopoietic stem cells Bridenbaugh, Stephanie

111 3 p. 1735-1738
artikel
20 Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia Charles, Edgar D.

111 3 p. 1344-1356
artikel
21 Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke Pruissen, D. Martijn O.

111 3 p. 1282-1286
artikel
22 Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma Chauhan, Dharminder

111 3 p. 1654-1664
artikel
23 Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene Du, Hong-Yan

111 3 p. 1128-1130
artikel
24 Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia Saddler, Chris

111 3 p. 1584-1593
artikel
25 Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas Ding, B. Belinda

111 3 p. 1515-1523
artikel
26 Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura Breunis, Willemijn B.

111 3 p. 1029-1038
artikel
27 CREB is a critical regulator of normal hematopoiesis and leukemogenesis Cheng, Jerry C.

111 3 p. 1182-1192
artikel
28 Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis Jobe, Shawn M.

111 3 p. 1257-1265
artikel
29 Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation Zhang, Linsheng

111 3 p. 1193-1200
artikel
30 Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression Herens, Christian

111 3 p. 1745-1746
artikel
31 Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study Forestier, Erik

111 3 p. 1575-1583
artikel
32 Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation Schade, Andrew E.

111 3 p. 1366-1377
artikel
33 Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis Merkulov, Sergei

111 3 p. 1274-1281
artikel
34 Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency Nyfeler, Beat

111 3 p. 1299-1301
artikel
35 Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo Franki, Suzanne N.

111 3 p. 1504-1511
artikel
36 Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia Archambeault, Sophie

111 3 p. 1124-1127
artikel
37 Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels Au, Patrick

111 3 p. 1302-1305
artikel
38 Different partners in different places? Cancro, Michael P.

111 3 p. 975
artikel
39 Editorial Board
111 3 p. i
artikel
40 Effects of dietary restriction on hematopoietic stem-cell aging are genetically regulated Ertl, Robin P.

111 3 p. 1709-1716
artikel
41 Erratum in Liu et al. “A potent erythropoietin-mimicking human antibody interacts through a novel binding site,”
111 3 p. 996
artikel
42 Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency Józsi, Mihály

111 3 p. 1512-1514
artikel
43 Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment Hochhaus, Andreas

111 3 p. 1039-1043
artikel
44 Fibroblast growth factor controls the timing of Scl, Lmo2, and Runx1 expression during embryonic blood development Walmsley, Maggie

111 3 p. 1157-1166
artikel
45 Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIA Peterson, Julie A.

111 3 p. 1234-1239
artikel
46 Fixing bones before birth Flake, Alan W.

111 3 p. 978-979
artikel
47 FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications Whitman, Susan P.

111 3 p. 1552-1559
artikel
48 FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia Kim, Hyung-Gyoon

111 3 p. 1567-1574
artikel
49 Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions Shida, Yasuaki

111 3 p. 1295-1298
artikel
50 Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference Ortega-Paino, Eva

111 3 p. 1617-1624
artikel
51 Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RARα van Wageningen, Sake

111 3 p. 1634-1643
artikel
52 Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer Egorina, Elena M.

111 3 p. 1208-1216
artikel
53 Historical review: megakaryopoiesis and thrombopoiesis Kaushansky, Kenneth

111 3 p. 981-986
artikel
54 Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7− lympho-myeloid thymic progenitors Hao, Qian-Lin

111 3 p. 1318-1326
artikel
55 Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells Cokic, Vladan P.

111 3 p. 1117-1123
artikel
56 Identification of distinct prognostic subgroups in low- and intermediate-1–risk myelodysplastic syndromes by flow cytometry van de Loosdrecht, Arjan A.

111 3 p. 1067-1077
artikel
57 Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia Visco, Carlo

111 3 p. 1110-1116
artikel
58 Indirect involvement of allergen-captured mast cells in antigen presentation Kambayashi, Taku

111 3 p. 1489-1496
artikel
59 Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by Rh immune globulin Zucker, Michal

111 3 p. 1306-1308
artikel
60 Induction of regulatory T cell–resistant helper CD4+ T cells by bacterial vector Nishikawa, Hiroyoshi

111 3 p. 1404-1412
artikel
61 Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre–B-cell receptor and promote cell-cycle withdrawal in pre–B-cell development Ma, Shibin

111 3 p. 1396-1403
artikel
62 Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice Guillot, Pascale V.

111 3 p. 1717-1725
artikel
63 Iron caught on the shuttle Weiss, Günter

111 3 p. 980
artikel
64 JAK2 V617F and ringed sideroblasts: not necessarily RARS-T Steensma, David P.

111 3 p. 1748
artikel
65 Junctional adhesion molecule-A, JAM-A, is a novel cell-surface marker for long-term repopulating hematopoietic stem cells Sugano, Yasuyoshi

111 3 p. 1167-1172
artikel
66 Late effects of myeloablative bone marrow transplantation (BMT) in sickle cell disease (SCD) Fitzhugh, Courtney D.

111 3 p. 1742-1743
artikel
67 Lentiviral (HIV)-based RNA interference screen in human B-cell receptor regulatory networks reveals MCL1-induced oncogenic pathways Ruiz-Vela, Antonio

111 3 p. 1665-1676
artikel
68 Live imaging of emerging hematopoietic stem cells and early thymus colonization Kissa, Karima

111 3 p. 1147-1156
artikel
69 LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1 Rastelli, Julia

111 3 p. 1448-1455
artikel
70 Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines Pathan, Nuzhat I.

111 3 p. 1594-1602
artikel
71 Mesenchymal stem cells inhibit natural killer–cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2 Spaggiari, Grazia Maria

111 3 p. 1327-1333
artikel
72 Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression Wondergem, Marielle J.

111 3 p. 1739
artikel
73 Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8–specific CD8+ T cells Guihot, Amélie

111 3 p. 1387-1395
artikel
74 NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement Wang, Siao-Yi

111 3 p. 1456-1463
artikel
75 NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities Diermayr, Stefan

111 3 p. 1428-1436
artikel
76 Normal no more Suarez-Saiz, Fernando

111 3 p. 977-978
artikel
77 Not too late for imatinib Mesa, Ruben A.

111 3 p. 973-974
artikel
78 On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis Hadinoto, Vey

111 3 p. 1420-1427
artikel
79 Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group Lange, Beverly J.

111 3 p. 1044-1053
artikel
80 Peripheral blood blast clearance during induction therapy in acute myeloid leukemia Gianfaldoni, Giacomo

111 3 p. 1746-1747
artikel
81 Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes Garcia-Manero, Guillermo

111 3 p. 1060-1066
artikel
82 Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis Rovó, Alicia

111 3 p. 1740-1741
artikel
83 Pim-1 and Pim-2 kinases are required for efficient pre–B-cell transformation by v-Abl oncogene Chen, Ji-Long

111 3 p. 1677-1685
artikel
84 Platelet-associated PF-4 as a biomarker of early tumor growth Cervi, David

111 3 p. 1201-1207
artikel
85 Platelets may serve up biomarkers Sachais, Bruce S.

111 3 p. 974
artikel
86 Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study Le Deley, Marie-Cécile

111 3 p. 1560-1566
artikel
87 Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia Kosaka, Yoshiyuki

111 3 p. 1054-1059
artikel
88 Protein kinase C–associated kinase is required for NF-κB signaling and survival in diffuse large B-cell lymphoma cells Kim, Sang-Woo

111 3 p. 1644-1653
artikel
89 Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications Sohn, Yang-Sung

111 3 p. 1690-1699
artikel
90 Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5 Chen, Yun

111 3 p. 1217-1226
artikel
91 Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase Aiba, Yuichi

111 3 p. 1497-1503
artikel
92 Repertoire and frequency of immune cells reactive to Epstein-Barr virus–derived autologous lymphoblastoid cell lines Bhaduri-McIntosh, Sumita

111 3 p. 1334-1343
artikel
93 Response: EBV reactivation in the immunosuppressed: to treat or not to treat? Scheinberg, Phillip

111 3 p. 1739-1740
artikel
94 Response: Late effects of myeloablative stem cell transplantation or late effects of sickle cell disease itself? Bernaudin, Françoise

111 3 p. 1744
artikel
95 Response: The 2008 World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: a paradigm of effective collaboration among clinicians, pathologists, and scientists Tefferi, Ayalew

111 3 p. 1742
artikel
96 Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway Elias, Kevin M.

111 3 p. 1013-1020
artikel
97 Revised criteria for the myeloproliferative disorders: too much too soon? Samuelson, Scott J.

111 3 p. 1741
artikel
98 RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses Schmitt, Michael

111 3 p. 1357-1365
artikel
99 Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study Coiffier, Bertrand

111 3 p. 1094-1100
artikel
100 Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis Sellick, Gabrielle S.

111 3 p. 1625-1633
artikel
101 Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years Syrjala, Karen L.

111 3 p. 989-996
artikel
102 Sexuality in long-term survivors Socié, Gerard

111 3 p. 972-973
artikel
103 Shear elegance: regulation of thrombus growth by shear stress Hobbs II, William E.

111 3 p. 972
artikel
104 Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders Pietra, Daniela

111 3 p. 1686-1689
artikel
105 Stem-cell trafficking at vascular borders Hutchinson, Sarah

111 3 p. 975-976
artikel
106 Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis Murray, Fiona

111 3 p. 1524-1533
artikel
107 Strontium can increase some osteoblasts without increasing hematopoietic stem cells Lymperi, Stefania

111 3 p. 1173-1181
artikel
108 TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts Bossen, Claudia

111 3 p. 1004-1012
artikel
109 The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition Chng, Wee J.

111 3 p. 1603-1609
artikel
110 The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity Behrens, Marshall D.

111 3 p. 1472-1479
artikel
111 The Modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6 −/− mice Cheli, Yann

111 3 p. 1266-1273
artikel
112 The role of Ikaros in human erythroid differentiation Dijon, Marilyne

111 3 p. 1138-1146
artikel
113 The tertiary structure and domain organization of coagulation factor VIII Shen, Betty W.

111 3 p. 1240-1247
artikel
114 The yin and yang of Fcγ receptors in ITP McKenzie, Steven E.

111 3 p. 971-972
artikel
115 The yin-yang of platelet granules Abrams, Charles S.

111 3 p. 979
artikel
116 Tissue factor in granulocytes: yes and NO Rao, L. Vijaya Mohan

111 3 p. 976-977
artikel
117 Transgenic blockade of interleukin 6 transsignaling abrogates inflammation Rabe, Björn

111 3 p. 1021-1028
artikel
118 Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void Solomon, Lawrence R.

111 3 p. 997-1003
artikel
119 Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results Adès, Lionel

111 3 p. 1078-1084
artikel
                             119 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland